EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.

Hans Jørgen AarstadArild Andrè ØsthusHelene Hersvik AarstadStein LybakAnne Kari H Aarstad

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2019)

EORTC H&N-35 QLQ scores at diagnosis and throughout the first year thereafter harbor prognostic power.

Keyphrases

squamous cell carcinoma
end stage renal disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
cross sectional
radiation therapy
patient reported outcomes
patient reported